cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0010357,C0009932,NEG_PROCESS_OF,Cross Reactions,Control Groups,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C0178575,C0008059,NEG_PROCESS_OF,cross immunity,Child,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C0178575,C0086418,NEG_PROCESS_OF,cross immunity,Homo sapiens,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C0597299,C0680399,NEG_PROCESS_OF,protein metabolism,reference group,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C0949765,C0034510,NEG_PROCESS_OF,Polyadenylation,Racial group,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C1150651,C0086418,NEG_PROCESS_OF,ligase activity,Homo sapiens,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C1704259,C0086418,NEG_PROCESS_OF,Biochemical Pathway,Homo sapiens,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C2247542,C0086418,NEG_PROCESS_OF,vetispiradiene synthase activity,Homo sapiens,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
C2753504,C0086418,NEG_PROCESS_OF,interleukin-35 receptor binding,Homo sapiens,moft,humn,1,NEG_PROCESS_OF_MOFTnprcfHUMN
